Skip to main content
OpenTrials
Completed

NCT Number: NCT00925717

of PATient Education Related to CV Risk factOrs in Type 2 Diabetes Mellitus(Patrol).

An observational, non-interventional, multi-centre study to provide further information on the utility of test for a predictive marker by investigating the current prevalence of high sensitivity CRP (hs-CRP) testing and characteristics of each CVD risk group.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Low Density Lipoprotein Cholesterol Goal Achievement

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Research Site, Cheonan-si, Chungchungnam-do, South Korea

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Subjects who was diagnosed as diabetes
  • Subjects who was diagnosed as dyslipidaemia or takes lipid lowering medication
  • Clinic visit in the past 6 months more than once

Exclusion criteria

  • Subjects who are unwilling or unable to provide their examination and lab result of medical chart.

Treatment and study plan

Primary outcomes

  1. Investigate LDL-C goal achievement rate according to ADA recommendation

    Time frame: Within the last 6 months from the date of data entry.

Secondary outcomes

  1. Investigate reduction of 10-year risk for CHD by using UKPDS risk engine

    Time frame: Within the last 6 months from the date of data entry.

Sponsors and collaborators

Lead sponsor

AstraZeneca

Industry

Registry information

Acronym: DART

Important dates

Study start
2009
Study completion
2009
First posted
Jun 22, 2009
Registry last updated
Jan 26, 2010

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.